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Brazilian pemphigus foliaceus (fogo selvagem) is a 
cutaneous blistering disease endemic to certain areas of 
South America that has distinctive epidemiologic fea-
tures suggestive of an infectious disease transmitted by 
an insect vector. Patients with the disease have anti-
epithelial autoantibodies, both circulating in the 
serum and bound to lesional epidermis. In order to ex-
amine the possible pathogenic role of these autoantibod-
ies, IgG from the sera of these patients was purified and 
injected into the peritoneum of neonatal BALB/c mice. 
Thirty-four of 46 mice (74%) receiving parenteral lgG 
fractions from these patients developed cutaneous le-
sions that were identical to the human disease by clini-
cal, histologic, immunologic, and ultrastructural crite-
ria. High- titer Brazilian pemphigus foliaceus sera pro-
duced lesions more consistently and rapidly than low-
titer sera. When injections were discontinued, new le-
sions ceased to appear and old lesions resolved. The 
extent of disease correlated with the titer of human 
antiepithelial antibodies detected in the mouse serum (z 
< 0.01). Similar concentrations of IgG fractions ob-
. tained from sera of unaffected Brazilians living in en-
demic areas and from American donors did not induce 
disease when injected into littermates. These results 
establish that the antiepithelial autoantibodies play an 
important role in the pathogenesis of the cutaneous le-
sions in Brazilian pemphigus foliaceus. 
Brazilian pemphigus foliaceus (BPF) is a chronic blistering 
disease of the skin, of which there are approximately 10,000 
registered active cases [1). The disease is endemic in areas of 
South America, particularly central Brazil, where it is known 
as fogo selvagem. It occurs most frequently in rural areas where 
the jungle is being cleared for settlement, but becomes rare as 
these regions become urbanized. The onset of the disease is 
frequently abrupt, with malaise and fever; it occurs predomi-
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nantly in children and young adults and often affects several 
members of the same household (2]. These epidemiologic fea-
tures suggest an infectious etiology, but a virus or other infec-
tious agent has not yet been identified (3]. A consistent feature 
of the disease is the presence of high-titer antiepidermal cell 
surface autoantibodies, demonstrable in lesional skin and cir-
culating in the serum by immunofluorescence (IF) [4] and 
immunoelectron microscopy (immuno-EM) techniques [5,6]. 
These autoantibodies are detected in all epidermal layers, 
bound diffusely to the keratinocyte cell surface, without pref-
erential binding to desmosomes (6]. Ultrastructural studies (6] 
have clemonstrated that the epidermal cell-cell detachment 
(acantholysis) in lesional epidermis of BPF is localized in the 
granular cell layer of the epidermis, with preservation of the 
normal morphology of the basal and spinous cell layer. This 
process begins with widening of the intercellular spaces (ICS) 
between desmosomes, and progresses until the desmosomal 
units separate. When acantholysis is complete, the split des-
mosomes cannot be visualized and t he tonofilaments retract to 
the perinuclear area. 
Our laboratory previously described [7] an animal model to 
demonstrate and study the pathogenic effects of the autoanti-
bodies from patients with pemphigus vulgaris (PV), a disorder 
in which the acantholytic process occurs primarily just above 
the basal cells rather than through the granular cell layer. In 
order to examine the role of autoantibodies in BPF, we purified 
lgG fractions from the serum of patients with the disease and 
injected the immunoglobulins parenterally into neonatal 
BALB/c mice. 
MATERIALS AND METHODS 
Patient Population and Controls 
Serum was obtained from 10 patients (5 males, 5 fema les) living in 
endemic areas of Brazil who fulfilled the clinical, histologic, and IF 
criteria for the diagnosis of BPF. In order to eliminate any possible 
cases of pemphigus erythematosus (Senear-Usher syndrome) , which 
may resemble early stages of BPF, all sera were screened and were 
found to be negative for ANA, rheumatoid factor, and antibodies to 
extractable nuclear antigens Ro/SSA, La/SSB, nRNP, and Sm by 
standard techniques [8,9]. The patients ranged in age from 12-64 years 
(mean: 38) and had the disease for an average of 2.63 years (range: 4 
months to 6 years). The racial distribution was representative of that 
in the general population in the region. 
Control IgG were obtained from 2 groups: (1) pooled serum from 30 
unaffected Brazilians donors living in endemic areas, and (2) pooled 
normal human serum from 20 American donors. 
JgG Fractions 
IgG fractions were prepared from test (BPF) and control sera in 
identical fashion, either by affinity chromatography using staphylococ-
cal protein A [10] or by 40% ammonium sulfate precipitation using 
standard techniques. IgG concentrations were measured by immuno-
nephelometry using goat antihuman lgG. BPF antibody titers were 
determined by indirect IF using rat-tongue epithelium as the tissue 
substrate and fluorescein isothiocyanate (FITC)-conjugated goat anti-
human IgG as described by others [11]. Affinity-purified IgG fractions 
were tested for IgA and lgM contaminants by double immunodiffusion. 
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Animal Evaluation, Injection Technique, and JgG Dose 
Neonatal BALB/c mice were obtained from a breeding colony. 
Alternate littermates received either BPF or control lgG fractions. 
Purified lgG fractions were injected i.p. in a dose of 10 mg/g body 
weight twice daily for a total of 4 injections [7]. This was done 
identically for both the experimenta l and control animals. The extent 
of cutaneous disease was scored empirically as follows: 0 =no cutaneous 
lesions, + = localized cutaneous blisters or erosions only, and ++ = 
extensive ep idermal sloughing that occurred spontaneously or could be 
induced by gentle stroking, producing a positive Nikolsky sign. 
S e rum Determinations and Tissue Examination 
Mice were sacrificed by decapitation 12 h afte r the last injection and 
serum was obtained fo r measurement of total human lgG concentration 
by immunonephelometry and human pemphigus antiborly titers by 
indirect IF. The relationship between the serum levels ofBPF antibody 
titers and the extent of clinical disease was analyzed by the test for 
trend of Cochran [12]. Tissue specimens were processed by standard 
techniques for light microscopy, electron microscopy (EM) [13], im-
muno-EM [14], and direct IF using FITC-conjugated antihuman IgG 
(Cappel) [11]. 
RESULTS 
Characteristics of JgG Fractions 
Antiepidermal autoantibodies were detected in all 10 BPF 
sera. The titers of the individual sera are listed in Table I. Both 
groups of control sera were neg!ltive for autoantibodies. The 
IgG fraction that was prepared by affinity chromatography had 
no detectable IgA or IgM by double immunodiffusion. 
Clinical Evalu.ation of Animals Receiving Injections 
Thirty-four of 46 animals (74%) that received BPF IgG 
developed cutaneous lesions. Some developed lesions as early 
as 14 h after the initial injection, while repeated injections were 
required in others. IgG fractions with a high antiepithelial 
antibody titer generally produced lesions more quickly than 
low-titer IgG fractions. There was no difference in the in vivo 
effect of immunoglobulin fractions prepared by ammonium 
sulfate precipitation or by affinity chromatography. Changes 
in the skin consisted of either localized superficial blisters and 
erosions or more extensive and confluent superficial sloughing, 
with a positive Nikolsky sign (Fig 1). In one litter, injections 
of BPF lgG were discontinued after lesions had appeared, and 
TABLE I. Comparison of the serum titer of pem.phigu.s JgG from 
individual patients with the pathogenic effects of their JgG fractions to 
murine epidermis in vivo 
Patient initia ls 
and ages (years) 
Serum t iter 
of pemphigus 
antibodies 
Number of mice 
With les ions Without lesions 
Brazilian Pemphigus Foliaceus Sera 
LCR/ 36 1:10240 12 2 
PBA I 29 1:5120 6 0 
MES I 12 1:2560 3 1 
OBA I 37 1:1280 3 0 
BSS I 37 1:1280 3 1 
JAS I 32 1:1280 1 1 
PJN I 58 1:640 3 0 
LCVMI23 1:640 1 1 
ABB / 30 1:320 2 2 
APS I 64 1:320 0 4 
Total 34(74 %) 12(26%) 
Control Sera 
Pooled serum from 0 0 30 
normal Americans 
Pooled serum from 0 0 10 
unaffected Brazil-
ians in endemic 
areas 
Total 0 40 
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FIG 1. Clinical appearance of neonatal mouse injected with IgG 
fractions prepared from the serum of patients with BPF. Large super-
ficial ulceration (arrowhead) and a positive Nikolsky sign. 
healing occurred within 48-96 h. None of the 40 animals that 
received control lgG injections in identical doses developed any 
cutaneous lesions. 
Histologic and Ultrastru.ctu.ral Evaluation of Skin Lesions 
Light microscopic examination of lesions showed an intra-
epidermal vesicle or cleft that was always located through the 
granular cell layer. Epidermal cells in this area showed rounding 
and cell-cell detachment (acantholysis). The lower cell layers 
of the epidermis were not affected (Fig 2A ). 
EM examination of skin lesions confirmed t hat acantholysis 
involved only the granular cell layer of the epidermis (Fig 2B). 
Initial widening of the ICS occurred in regions of the cell 
surface between desmosomes (Fig 2C), and separation of des-
mosomes into split desmosomes occurred later. Disappearance 
of split desmosomes and perinuclear tonofilament retraction 
was seen in fully developed acantholytic cells. There were no 
significant ultrastructural alterations in the lower epidermal 
layers. 
Direct IF and Immuno-EM of Mouse Skin 
By direct IF all animals that were injected with the IgG 
fractions from patients with BPF showed binding of human 
IgG to the epidermal cell surfaces, with no preferential binding 
in the granular cell layer (Fig 3A ). Binding was also observed 
in uninvolved skin and, with slightly less intensity, in the oral 
mucosa. None of the animals that received IgG from either 
control population showed a p')sitive direct IF. 
Immuno-EM microscopy of perilesional skin from animals 
that received IgG fractions from the serum of patients with 
BPF showed diffuse binding of the human antibody to the cell 
surface of keratinocytes of all cell layers (Fig 3B). The immu-
noreactants were not seen concentrated either in or between 
desmosomes. Similar studies performed on animals receiving 
control IgG fractions did not show any specific deposition of 
immunoreactants within the epidermis. 
Relationship of BPF Antibody Titers to Cu.taneous Disease in 
Mice Given Human JgG 
All animals that received injections of IgG from patients with 
BPF had detectable serum levels of human pemphigus auto-
antibodies by indirect IF. The distribution of the BPF antibody 
titers is shown in Fig 4. The median titer for those animals 
without lesions (grade 0) was 80; for those with localized lesions 
(grade +) it was 160; and for those with a positive Nikolsky 
sign (grade ++) it was 1280. This relationship between BPF 
antibody titer and disease extent is statistically significant (z 
< 0.01) by the Cochran test for trend. The association between 
titers and disease extent was also true for individual sera. As 
shown in Table I, high-titer sera produced lesions far more 
frequently than did low-titer sera. In addition, high-titer sera 
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FIG 3. A, Direct immunofluorescence of skin from a neonatal mouse 
injected with antibodies from the sera of patients with BPF. The 
binding of human JgG to the epidermal cell surfaces is ident ical to that 
seen in humans with the disease. B, Immunoelectron microscopy of 
perilesional epidermis. The reaction products indicate binding of hu-
man lgG on the epidermal cell surfaces. Note the slight widening of 
the ICS which represents early acantholysis (bar= 11im). 
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FIG 2. Histologic appearance of skin 
lesions from neonatal BALB/c mice t hat 
had received lgG fractions prepared from 
the serum of patients wit h BPF. A, Light 
microscopy of tissue stained with hema-
toxylin and eosin. Superficial blisters oc-
curred only in the granular ce ll laye r. 
Open arrow points to acantholytic cells 
(X 100). B, Electron microscopy of an 
epidermal les ion. Asterisks indicate the 
widened ICS. Arrows point to the kera-
tohyaline granules t hat identify the cells 
of the granular ce ll layer. The stratum 
corneum can be seen above and the stra-
tum spinosum below (bar = 1 lim). C, 
Higher magnification of early acantha-
lytic changes. Widening of the ICS (as-
terisks) is evident in areas of the cell 
membrane between in tact desmosomes 
(arrowheads). Cell membranes are 
highly convoluted and tonofilaments re-
main attached to the desmosomes (bar 
= 11im). 
often produced disease within 14 h, while low-titer sera usually 
required 36-48 h, if they were to produce lesions at all. 
None of the animals that received control IgG injections had 
lesions or a positive indirect IF, although total human IgG 
concentration, as measured by immunonephelometry, was sim-
ilar in both test and control animals. For those that received 
BPF IgG, the serum value was 17.09 ± 0.93 mg/ml (mean ± 
SEM); for those that received control IgG fractions, the serum 
value was 17.99 ± 1.68 mg/ml. These means are not signifi-
cantly different by the Student t-test. 
DISCUSSION 
In 1968, Beutner et al [4] used IF techniques to detect the 
presence of autoantibodies in patients with BPF that bound to 
squamous epithelial cell surfaces. This followed their earlier 
report [15] of the presence of antiepithelial autoantibodies in 
the serum of patients with PV. The pattern of binding by direct 
or indirect IF was indist inguishable in both clinical forms of 
pemphigus. The relationship of these autoantibodies to the 
disease process, and the relationship of these two diseases to 
each other remained unclear. 
The findings reported in this paper fulfill several of the 
criteria necessary to establish a pathogenic role for the auto-
antibodies in BPF. The IgG fractions isolated from BPF sera 
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FIG 4. Relationship between the extent of disease induced in neo-
natal mice and the titer of human BPF autoantibodies in the mouse 
sera. Disease extent was graded (0] if no lesions could be seen or 
induced by gently stroking; [ +] if lesions could be seen but gentle 
stroking did not detach the surrounding skin; or l ++] if gentle stroking 
did detach the surrounding skin (see Fig 1). The correlation between 
more extensive cutaneous disease and higher serum titers of human 
autoantibodies was highly significant (z < 0.01). 
consistently produced cutaneous disease in the mice while the 
IgG fractions from the sera of normal individuals from endemic 
areas of Brazil and from American donors did not produce any 
skin lesions. The concentrations of control IgG in the animal 
serum were comparable to those found in the experimental 
group injected with BPF IgG. As shown in Table I, those IgG 
fractions from BPF sera with high titers of autoantibodies were 
successful in producing lesions most consistently, and often as 
early as 14 h after injection. The cutaneous disease induced in 
mice by BPF IgG varied in severity, from localized superficial 
erosions to widespread cutaneous disease with a positive Ni-
kolsky sign. There was a close correlation between more exten-
sive disease and higher titers of human BPF antibody in the 
mouse serum. When injections of BPF IgG were discontinued, 
new lesions ceased to appear, and then existing lesions resolved. 
Finally, the cutaneous disease induced in mice by BPF auto-
antibodies was distinct from that produced by PV autoantibod-
ies in the same mouse model. 
Our previous study had demonstrated that the IgG fractions 
from PV sera injected into neonatal mice produced suprabasilar 
acantholysis in the epidermis [7]. With high concentrations of 
PV IgG, blisters occurred in the subgranular cell layer, but 
there were early acantholytic changes in the suprabasilar layers 
also. These changes in the lower epidermis were not seen in 
lesions induced by BPF IgG, either by light or EM examination, 
indicating that BPF and PV autoantibodies affect two different 
populations of keratinocytes. Despite this, in both BPF and 
PV, autoantibodies bound diffusely to keratinocyte cell surfaces 
without preference for the cell layer affected. 
In order to reconcile the apparent discrepancy between the 
level of histologic cleavage and the IF findings, it seems likely 
that PV and BPF IgG contain a heterogeneous population of 
autoantibodies directed against different antigens or epitopes 
located on squamous epithelial cell surfaces. This heteroge-
neous population is responsible for the IF pattern. On the other 
hand, the pathogenic BPF and PV autoantibodies may com-
prise only one fraction of the anti-ICS autoantibodies and bind 
to antigens or epitopes that are different and peculiar to the 
subpopulation of keratinocytes directly affected in each disease. 
Recent studies by Stanley et al [16] and Koulu et al [17] have 
shown that autoantibodies from some patients with nonen-
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demic pemphigus foliaceus bind to a 160 kD desmosomal gly-
coprotein that is distinct from the antigen recognized by PV 
autoantibodies, which is a 130 kD glycoprotein. However, it is 
not yet known whether these are the pathogenic antibodies. 
Peterson and Wuepper [18] have isolated a 66 kD glycoprotein 
using antibodies from patients with PV and were able to 
reproduce the disease in mice after injecting them with anti-
bodies that had been raised against the 66 kD band. 
Taken together, these observations strongly suggest that PV 
and BPF are diseases mediated by different autoantibodies 
rather than being different individual responses to the same 
autoantibody, particularly because BALB/c mice are geneti-
cally quite homogeneous. Autoantibodies have been implicated 
in the pathogenesis of several autoimmune disorders; however, 
passive transfer of disease to animals has been successfully 
demonstrated in only a few of these conditions [7,19,20]. The 
present study establishes that BPF can be included in this 
select group of human diseases. A key point, not directly 
addressed in this study, is the epidemiologic data that strongly 
suggest that BPF may be a human autoimmune disease that is 
triggered by an infectious agent. This may prove to be an 
important area of future investigation. 
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